CIAM
JSPR icon

Caitong International Asset Management’s Jasper Therapeutics JSPR Stock Holding History

Caitong International Asset Management’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
1
– – ﹤0.01% 3229
2026
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 2485
2025
Q3 		– Sell
-111
Closed -$616 – 2233
2025
Q2 		$616 Sell
111
-909
-89% -$4.47K ﹤0.01% 1672
2025
Q1 		$4.39K Buy
+1,020
New +$6.79K ﹤0.01% 1057

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caitong International Asset Management's JSPR Position: Q2 2026 in Review

Caitong International Asset Management held its Jasper Therapeutics (JSPR) position steady in Q2 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3229.

Caitong International Asset Management first reported a position in JSPR in Q1 2025 and has held it in 4 quarters since. The position peaked at $4.39K in Q1 2025. 45 funds tracked by Wall St. Rank hold JSPR as of Q2 2026.

  • Caitong International Asset Management held 1 share of Jasper Therapeutics worth $0 as of Q2 2026.
  • Caitong International Asset Management left its Jasper Therapeutics share count unchanged in Q2 2026.
  • Jasper Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #3229 holding.
  • Caitong International Asset Management first reported a position in Jasper Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Caitong International Asset Management's Jasper Therapeutics position peaked at $4.39K in Q1 2025.
  • 45 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.